Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000545004 | SCV000641681 | likely benign | Tuberous sclerosis 1 | 2024-01-28 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002448705 | SCV002682933 | likely benign | Hereditary cancer-predisposing syndrome | 2019-12-30 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
All of Us Research Program, |
RCV003999231 | SCV004840507 | likely benign | Tuberous sclerosis syndrome | 2023-11-20 | criteria provided, single submitter | clinical testing | |
Clinical Genetics, |
RCV001729630 | SCV001979120 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001729631 | SCV001980344 | benign | not specified | no assertion criteria provided | clinical testing |